Catalyst deal for Materia and Sigma
range of catalysts that are used in pharmaceutical discovery and
fine chemical production.
Sigma-Aldrich of the USA has negotiated an exclusive contract to distribute research quantities of a range of catalysts developed by Materia that are used in pharmaceutical discovery and fine chemical production.
Sigma has taken over the distribution of Materia's Grubbs' and Hoveyda-Grubbs' Catalysts, based on its metathesis technology, for a 10-year period after the latter company terminated all its relationships with other distributors for these products.
Geoff Irvine, manager business development for Sigma, said Materia's metathesis technology is an ideal addition to its growing portfolio of catalysts for pharmaceutical discovery and fine chemicals production. "The Grubbs catalysts enable unique transformations on complex molecules and are already a mainstay of synthetic and medicinal chemists," said Irvine in a statement.
Other catalogue companies and resellers who have been or are found to be operating without a license from Materia will be notified of their infringement and required to discontinue their representation of these products.
